Skip to content
Catalog
You are not logged in |Login  
Add to My Lists Add to Bag MARC Display Return to Browse Limit/Sort Search More Information
     
Limit search to available items
Previous Record Next Record
Book Cover
Bestseller
BestsellerE-Book
Author Ugurlu, Ali Seyhan.

Title Bioethics and the Patent Eligibility of Human Embryonic Stem Cells-Related Inventions in Europe / Ali Seyhan Uğurlu.

Publication Info. Baden-Baden : Nomos Verlagsgesellschaft, 2014.

Copies

Location Call No. Status
 All Libraries - Shared Downloadable Materials  JSTOR Open Access Ebook    Downloadable
All patrons click here to access this title from JSTOR
 University of Saint Joseph: Pope Pius XII Library - Internet  WORLD WIDE WEB E-BOOK JSTOR    Downloadable
Please click here to access this JSTOR resource
Description 1 online resource (87 pages).
Series Munich Intellectual Property Law Center - MIPLC ; v. 22
Munich Intellectual Property Law Center - MIPLC.
Note Print version record.
Contents Cover; I. Introduction; II. Background to the Science; A. What Are Stem Cells?; B. Source of stem cells; 1. Adult Stem Cells; 2. ESCs; 3. iPSCs; III. Legal Provisions Applicable to the Patent Eligibility of hESC-Related Inventions; A. EPC; B. TRIPs; C. EC 98/44 Directive; IV. Ethics and Stem Cell Related Patents; A. Ethics and Patent Law; 1. Patent Law Isolated from Morality Based Provisions? A Look into the Legislative Discretion; a) A Closer Look at the EPC; b) Specific Examples of Immorality in the Biotech Directive; B. Bioethics and Patents for hESC-Related Inventions.
1. Moral Status of Human Embryos and Its Implications for the hESC Researcha) Debate on whether Human Embryo Has Human Dignity; b) Double-Edged Sword: A Need of Compromise Considering Different Methods of Obtaining hESCs; (1) Research on Embryos Within 14 days After Fertilisation; (2) Research with Supernumerous Embryos; (3) Research with Embryos from SCNT; V. The Panorama in Europe; A. Determining the Right Interpretation of the Biotech Directive; 1. The Patent Eligibility of the Human Embryo; 2. The Patent Eligibility of hESC-related Inventions.
A) The Destruction of Human Embryos for hESCsb) The Creation of Human Embryos for hESCs; B. Application of the EPC; 1. Lack of Uniform Moral Standard; 2. Attempts to Create a Uniform Morality Standard; VI. EPO's Web of Precedents; A. University of Edinburgh Case; B. The WARF Case; 1. Background; 2. The Rationale; VII. CJEU's Brüstle Judgment; A. Background; B. The Rationale; C. Comparison of WARF and Brüstle Cases; D. The Devil is in Details, Unpatentable but Exploitable?; E. Implications of the CJEU's Judgment to the Future of hESC-Related Inventions; 1. Germany.
2. The U.K.3. The EPO; VIII. Conclusion; Annex; List of Works Cited.
Summary Neu entstehende Technologien wie die Biotechnologie stellen eine Kontroverse und Herausforderung für das Patentrecht dar. Das Werk analysiert die neuesten Entwicklungen in der Rechtsprechung zur Zulässigkeit von Patenten im Rahmen der Stammzellen-Forschung in Europa. ReiheMunich Intellectual Property Law Center - MIPLC - Band 22.
Subject Fetus -- Research -- Moral and ethical aspects.
Human embryo -- Transplantation -- United States.
Stem cells.
LAW / Constitutional.
Patent laws and legislation -- European Union countries.
Embryonic stem cells -- Research -- Moral and ethical aspects.
Other Form: Print version: Ugurlu, Ali Seyhan. Bioethics and the Patent Eligibility of Human Embryonic Stem Cells-Related Inventions in Europe. Baden-Baden : Nomos Verlagsgesellschaft, ©2014 9783848714711
ISBN 9783845255149 electronic bk.
3845255145 electronic bk.
-->
Permanent Link
Add a Review

 

Library Links

Encore

Search Tools

Language Settings

English
Español